Novolin 70/30



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Diabetes Mellitus 18.3%
Type 2 Diabetes Mellitus 16.0%
Insulin-requiring Type Ii Diabetes Mellitus 9.4%
Product Used For Unknown Indication 9.4%
Insulin-requiring Type 2 Diabetes Mellitus 8.4%
Type 1 Diabetes Mellitus 7.9%
Hypertension 6.9%
Ill-defined Disorder 5.7%
Off Label Use 3.0%
Chronic Obstructive Pulmonary Disease 2.2%
Drug Use For Unknown Indication 2.2%
Blood Pressure Increased 2.0%
Asthma 1.7%
Bronchiectasis 1.2%
Diabetes Mellitus Insulin-dependent 1.2%
Gastrooesophageal Reflux Disease 1.2%
Blood Cholesterol Increased 1.0%
Blood Pressure 0.7%
Cardiovascular Event Prophylaxis 0.7%
Dyspepsia 0.7%
Blood Glucose Increased 11.6%
Hypoglycaemic Unconsciousness 11.6%
Blood Glucose Decreased 10.7%
Hypoglycaemia 6.3%
Loss Of Consciousness 5.4%
Medication Error 5.4%
Vision Blurred 5.4%
Myocardial Infarction 4.5%
Nausea 4.5%
Victim Of Crime 4.5%
Injection Site Irritation 3.6%
Product Quality Issue 3.6%
Victim Of Homicide 3.6%
Wrong Drug Administered 3.6%
Blood Glucose Fluctuation 2.7%
Convulsion 2.7%
Death 2.7%
Dyspnoea 2.7%
Incorrect Storage Of Drug 2.7%
Mental Status Changes 2.7%
Secondary
Type 2 Diabetes Mellitus 25.8%
Diabetes Mellitus 11.7%
Type 1 Diabetes Mellitus 9.2%
Insulin-requiring Type 2 Diabetes Mellitus 7.9%
Insulin-requiring Type Ii Diabetes Mellitus 6.7%
Product Used For Unknown Indication 5.8%
Drug Use For Unknown Indication 4.6%
Hypertension 4.2%
Prostatomegaly 4.2%
Blood Cholesterol Increased 2.9%
Arrhythmia 2.1%
Oedema Peripheral 2.1%
Anaemia 1.7%
Insomnia 1.7%
Nasal Congestion 1.7%
Oedema 1.7%
Pain In Extremity 1.7%
Pain Management 1.7%
Restless Legs Syndrome 1.7%
Blood Pressure 1.3%
Hypoglycaemic Unconsciousness 17.6%
Fatigue 11.8%
Pancreatitis 7.8%
Vision Blurred 7.8%
Cerebrovascular Accident 5.9%
Wrong Drug Administered 5.9%
Blood Glucose Increased 3.9%
Diabetes Mellitus Inadequate Control 3.9%
Dyspnoea 3.9%
Glycosylated Haemoglobin Increased 3.9%
Malaise 3.9%
Transient Ischaemic Attack 3.9%
Urinary Tract Infection 3.9%
White Blood Cells Urine Positive 3.9%
Anaphylactic Reaction 2.0%
Angina Pectoris 2.0%
Cardiac Failure 2.0%
Cardiac Failure Congestive 2.0%
Circumstance Or Information Capable Of Leading To Medication Error 2.0%
Convulsion 2.0%
Concomitant
Product Used For Unknown Indication 61.5%
Drug Use For Unknown Indication 12.7%
Diabetes Mellitus 6.3%
Hypertension 3.2%
Type 2 Diabetes Mellitus 2.5%
Prophylaxis 2.2%
Pain 1.7%
Diabetes Mellitus Non-insulin-dependent 1.3%
Blood Cholesterol Increased 1.0%
Depression 1.0%
Rheumatoid Arthritis 0.9%
Atrial Fibrillation 0.8%
Type 1 Diabetes Mellitus 0.8%
Cardiac Operation 0.7%
Arthritis 0.6%
Cardiac Disorder 0.6%
Renal Transplant 0.6%
Renal Cell Carcinoma 0.6%
Osteoporosis 0.5%
Anxiety 0.5%
Weight Decreased 19.0%
Vomiting 10.8%
Blood Glucose Increased 8.5%
Nausea 7.6%
Weight Increased 5.8%
Death 5.0%
Drug Ineffective 4.1%
Pain 4.1%
Renal Failure 3.8%
Thrombosis 3.8%
Myocardial Infarction 3.2%
Renal Failure Acute 3.2%
Type 2 Diabetes Mellitus 2.9%
White Blood Cell Count Decreased 2.9%
Therapeutic Response Decreased 2.6%
Thrombocytopenia 2.6%
Urinary Tract Infection 2.6%
Vision Blurred 2.6%
Tremor 2.3%
Urosepsis 2.3%